[18]
Astra and Takeda submit, and tendered evidence to establish, that the drug LOSEC is a commercially successful and economically important drug to each of them. Counsel representing Astra at the hearing (not on the motion) swore an affidavit stating that the proceeding was one of the most complex proceedings with which he had been involved both from a legal and scientific perspective. Takeda submitted evidence that a patent agent assisted counsel in preparation for the hearing and at the hearing.